MICHELE GRAZIOSI: Open Payments
NPI 1194473215 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 9 payments from 6 companies in 2025. Trend: 2023 $699 · 2024 $275 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Lilly USA, LLC | 2 | $42 |
| ABBVIE INC. | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Lundbeck LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: CAPLYTA, UBRELVY, TRELEGY ELLIPTA, MOUNJARO, REXULTI, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
